Antigenics Inc. (New York) (AGEN) Cancer Vaccine Gets Negative EU Panel Vote
11/20/2009 8:24:27 AM
More...
|
Antigenics Inc. (New York) (AGEN) Buoyed by Brain-Cancer Study
10/26/2009 8:03:13 AM
More...
|
Antigenics Inc. (New York) (AGEN) to Report Third Quarter 2009 Financial Results on October 29, 2009; Conference Call to Follow
10/22/2009 9:40:32 AM
More...
|
Antigenics Inc. (Lexington, MA) (AGEN) to Raise $10 Million in Private Placement
8/4/2009 7:37:57 AM
More...
|
Antigenics Inc. (Lexington, MA) (AGEN) to Raise $10 Million in Private Placement
7/31/2009 8:28:34 AM
More...
|
Antigenics Inc. (New York) (AGEN) to Report Second Quarter 2009 Financial Results on July 30 2009; Conference Call to Follow
7/23/2009 9:46:57 AM
More...
|
Antigenics Inc. (New York) (AGEN) Regains NASDAQ Compliance
4/30/2009 1:28:44 PM
More...
|
Antigenics Inc. (New York) (AGEN) Brain Cancer Vaccine Gets Orphan Drug Status
4/29/2009 6:56:29 AM
More...
|
Antigenics Inc. (New York) (AGEN)’s Oncophage Cancer Vaccine Receives European Orphan Drug Designation for Brain Cancer
3/12/2009 8:45:45 AM
More...
|
Antigenics Inc. (New York) (AGEN) Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights
2/19/2009 9:02:39 AM
More...
|
|